III MD - ALR Technologies Medical Consultant
ALRTF Stock | 0.01 0 11.76% |
Insider
III MD is Medical Consultant of ALR Technologies
Age | 76 |
Phone | 804 554 3500 |
Web | https://www.alrt.com |
ALR Technologies Management Efficiency
The company has return on total asset (ROA) of (8.7276) % which means that it has lost $8.7276 on every $100 spent on assets. This is way below average. ALR Technologies' management efficiency ratios could be used to measure how well ALR Technologies manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Matt Jarboe | Paragon 28 | N/A | |
David Colleran | Anika Therapeutics | 52 | |
Moji James | Avanos Medical | N/A | |
Denice Torres | Glaukos Corp | 60 | |
Amy Horton | Artivion | 50 | |
Leana Wen | Glaukos Corp | 37 | |
Mojirade James | Avanos Medical | 57 | |
David Crawford | Avanos Medical | N/A | |
Laverne Council | CONMED | 59 | |
Jesse Selnick | Sight Sciences | N/A | |
Meghan Scanlon | Paragon 28 | 48 | |
Dennis Maier | Artivion | 50 | |
Jason Edie | Paragon 28 | N/A | |
Rochelle Maney | Artivion | 45 | |
David MD | Sight Sciences | 54 | |
Ehab Esmail | Orthofix Medical | 52 | |
James Bullock | Artivion | 64 | |
Brendan Shook | Paragon 28 | N/A | |
BA Chemistry | Orthofix Medical | 63 | |
David Haffner | Glaukos Corp | N/A | |
Jeremy Hayden | Sight Sciences | 54 |
Management Performance
Return On Asset | -8.73 |
ALR Technologies Leadership Team
Elected by the shareholders, the ALR Technologies' board of directors comprises two types of representatives: ALR Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ALR. The board's role is to monitor ALR Technologies' management team and ensure that shareholders' interests are well served. ALR Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ALR Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Joe Stern, Head Health | ||
Barbara Dubiel, Consultant | ||
John Tolentino, Consultant | ||
Jacqueline Wu, Head Marketing | ||
III MD, Medical Consultant | ||
Sidney Chan, CEO, Chairman | ||
Mark Uy, Consultant | ||
Johnny Tlardera, Consultant | ||
Barrett Ehrlich, Consultant |
ALR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is ALR Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -8.73 | |||
Operating Margin | (390.28) % | |||
Current Valuation | 51.54 M | |||
Shares Outstanding | 551.97 M | |||
Shares Owned By Insiders | 69.70 % | |||
Price To Sales | 3,460 X | |||
Revenue | 7.47 K | |||
Gross Profit | 4.95 K | |||
EBITDA | (6.4 M) | |||
Net Income | (8.44 M) |
Currently Active Assets on Macroaxis
Other Information on Investing in ALR OTC Stock
ALR Technologies financial ratios help investors to determine whether ALR OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALR with respect to the benefits of owning ALR Technologies security.